Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"Nice Insight offers a unique perspective by tracking critical data relating
to the pharmaceutical CRO/CMO marketplace. The data they garner, as well as
their overall approach, puts them in a leading position for market
research."
Jeff Reinke editorial director, Pharmaceutical Processing & Manufacturing.net  
CPhI Worldwide
October 22-24 Messe Frankfurt, Germany |
Boehringer Ingelheim GmbH Catalent Pharma Solutions, Inc. Cirrus Pharmaceuticals CoreRx, Inc. DPT Laboratories, Ltd. Dr. Reddy's Laboratories Ltd. Laureate Biopharmaceutical Services, Inc. Lonza Quay Pharmaceuticals Recipharm AB
Ash Stevens, Inc. is a full service contract pharmaceutical manufacturer offering small-molecule drug substance development and cGMP manufacturing services. The company also provides contract research services to the National Institutes of Health and the National Cancer Institute. The company develops and manufactures APIs for commercial clients in the life sciences industry who are developing innovator small-molecule drugs. Services include: process development and scale-up; cGMP manufacturing; the development and cGMP manufacture of highly potent APIs using barrier-isolation technology; comprehensive analytical capabilities; and regulatory support for all phases of drug development and manufacturing.
http://
Regions
Stock Symbol Private Filter of 's services per Nice Insight Categories
Contact 
|
|
|
